MODY type 2 in Greig cephalopolysyndactyly syndrome (GCPS) as part of a contiguous gene deletion syndrome
- 16 August 2011
- journal article
- case report
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 155 (10) , 2469-2472
Abstract
Maturity‐onset diabetes of the young type 2 (MODY2) is a form of monogenic diabetes, characterized by mild fasting hyperglycemia. MODY2 is caused by heterozygous mutations in the GCK gene that encodes the glucokinase enzyme. We describe the clinical features and the underlying genetic defect of MODY2 in a patient with atypical Greig cephalopolysyndactyly syndrome (GCPS). The patient presented with the limb formation and the craniofacial developmental abnormalities typical to GCPS, in addition to mental retardation and epilepsy (assigned as atypical syndrome). Fasting hyperglycemia in the diabetic range, impaired glucose tolerance, and lack of diabetes autoantibodies were compatible with MODY2. In order to delineate the genetic aberrations relevant both to MODY2 and Greig syndrome in this patient, we performed cytogenetic analysis, real‐time PCR of the GCK gene, and comparative genomic hybridization (CGH) array. Cytogenetic study has shown a microscopic detectable deletion in the 7p13‐15 chromosomal region. Real‐time PCR demonstrated a deletion of the GCK gene in the patient but not her parents, and CGH array revealed a deleted region of approximately 12 Mb in the 7p13‐15 region. This deleted region included GLI3 and GCK genes (where heterozygous mutations cause GCPS and MODY2, respectively), and many other contiguous genes. Our patient manifests a unique form of MODY2, where GCK gene deletion is part of a large deleted segment in the 7p13‐15 chromosomal region.Keywords
This publication has 16 references indexed in Scilit:
- The Greig cephalopolysyndactyly syndromeOrphanet Journal of Rare Diseases, 2008
- Clinical implications of a molecular genetic classification of monogenic β-cell diabetesNature Clinical Practice Endocrinology & Metabolism, 2008
- Clinical and molecular delineation of the Greig cephalopolysyndactyly contiguous gene deletion syndrome and its distinction from acrocallosal syndromeAmerican Journal of Medical Genetics Part A, 2003
- Molecular Mechanisms and Clinical Pathophysiology of Maturity-Onset Diabetes of the YoungNew England Journal of Medicine, 2001
- Phenotype of five patients with Greig syndrome and microdeletion of 7p13American Journal of Medical Genetics, 2001
- Neonatal Diabetes Mellitus Due to Complete Glucokinase DeficiencyNew England Journal of Medicine, 2001
- beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations.Diabetes, 2001
- Point Mutations Throughout the GLI3 Gene Cause Greig Cephalopolysyndactyly SyndromeHuman Molecular Genetics, 1999
- Characterization of glucokinase mutations associated with maturity-onset diabetes of the young type 2 (MODY-2): different glucokinase defects lead to a common phenotype.Diabetes, 1999
- First-phase insulin release in normal childrenThe Journal of Pediatrics, 1993